Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Maryland
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Maryland
| Provider | Medicare | Services |
|---|---|---|
| Huslig, Richard M.D. | $0.39 | 212.3K |
| Nimmagadda, Gayatri M.D. | $0.39 | 210.1K |
| Meelu, M Ashraf MD | $0.38 | 122.9K |
| Xu, James M.D. | $0.40 | 114.8K |
| Boccia, Ralph M.D. | $0.40 | 88.2K |
| Shah, Minal M.D. | $0.40 | 76.0K |
| Priego, Victor M.D. | $0.40 | 75.0K |
| Tang, Yong M.D. | $0.40 | 72.4K |
| Bhandari, Arun MD | $0.38 | 59.2K |
| Markan, Yudhishtra M.D. | $0.38 | 56.1K |
| Ledakis, Panayotis MD | $0.39 | 55.1K |
| Seifter, Eric M.D. | $0.39 | 52.0K |
| Horrocks, Stephanie CRNP | $0.40 | 49.5K |
Maryland Pricing in Context
In Maryland, CPT code Q0138 (Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use)) carries an average Medicare payment of $0.39 — 0% above the national benchmark of $0.39. 101 providers across the state submitted claims for this procedure in 2023, performing 2.0M total services. Individual payments in MD ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Maryland is $3.07, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Maryland sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in Maryland lands near $1.00, with self-pay cash prices typically around $1.22. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cost in Maryland?
The average Medicare payment for Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Maryland is $0.39, which is 0% above the national average of $0.39. Providers in MD typically bill $3.07 for this procedure.
What does Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cost with insurance in Maryland?
With commercial insurance in Maryland, Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) costs an estimated $1.00. Without insurance, the estimated cash price is $1.22. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Maryland?
101 providers in Maryland billed Medicare for Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in 2023, performing 2.0M total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cheaper in Maryland than the national average?
No — Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) costs 0% above the national average in Maryland. The state average Medicare payment is $0.39 compared to $0.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.